IPP Bureau
Merck announces Phase 3 trial initiation for Bomedemstat
By IPP Bureau - August 27, 2024
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
Akums appoints Amrut Medhekar as CEO - CDMO Business
By IPP Bureau - August 26, 2024
e brings over 27+ years of rich pharmaceutical experience
Akums Q1 FY25 revenue up 5.1%
By IPP Bureau - August 26, 2024
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
Honeywell launches quality management system HQMR for Life Sciences industry
By IPP Bureau - August 26, 2024
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Shilpa Medicare announces positive outcome of Phase 3 studies of NorUDCA
By IPP Bureau - August 26, 2024
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
Royal Sense launches stergic dengue IgG/IgM rapid test
By IPP Bureau - August 25, 2024
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
Alembic receives FDA final approval for Betamethasone Valerate Foam, 0.12%
By IPP Bureau - August 25, 2024
BioIVT acquires ZenBio
By IPP Bureau - August 25, 2024
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
BI Sky Global successfully completes FDA MoCRA registration
By IPP Bureau - August 25, 2024
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Fasenra approved in China for the treatment of severe eosinophilic asthma
By IPP Bureau - August 25, 2024
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
By IPP Bureau - August 24, 2024
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
BioAge appoints former GSK CEO Jean-Pierre Garnier as Chair of its Board of Directors
By IPP Bureau - August 23, 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Pfizer and BioNTech receive FDA authorization for Omicron KP.2-adapted Covid-19 Vaccine
By IPP Bureau - August 23, 2024
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
Roche responds to WHO’s declaration of health emergency due to mpox outbreak
By IPP Bureau - August 23, 2024
Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants
Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
By IPP Bureau - August 23, 2024
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
